Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.1 SEK | +0.50% | -0.98% | -9.98% |
May. 08 | Boule Diagnostics AB Appoints Rikke Rytter as Director | CI |
May. 07 | Transcript : Boule Diagnostics AB, Q1 2024 Earnings Call, May 07, 2024 |
Business Summary
Number of employees: 228
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Consumables to Own Instruments
40.8
%
| 233 | 42.5 % | 233 | 40.8 % | +0.16% |
Instruments
32.1
%
| 159 | 28.9 % | 184 | 32.1 % | +15.78% |
Consumable Original Equipment Manufacturer and Clinical Diagnostic Solutions-Brand
20.0
%
| 113 | 20.5 % | 114 | 20.0 % | +1.32% |
Other
7.1
%
| 44 | 8.0 % | 40 | 7.1 % | -8.21% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
34.9
%
| 190 | 34.6 % | 199 | 34.9 % | +4.92% |
Asia
29.6
%
| 151 | 27.5 % | 169 | 29.6 % | +12.35% |
Africa/ Middle East
10.8
%
| - | - | 62 | 10.8 % | - |
Latin America
9.0
%
| 45 | 8.2 % | 52 | 9.0 % | +14.52% |
Western Europe
8.9
%
| 40 | 7.2 % | 51 | 8.9 % | +28.08% |
Eastern Europe
6.8
%
| 62 | 11.4 % | 39 | 6.8 % | -38.05% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Holger Lembrér
DFI | Director of Finance/CFO | - | Dec. 31 |
Aishat Bislieva
HRO | Human Resources Officer | - | 22-09-30 |
Fredrik Ekdahl
PRN | Corporate Officer/Principal | - | 11-12-31 |
Debbie Herrera
LAW | General Counsel | - | 16-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 20-12-31 | |
Chairman | 72 | 20-12-31 | |
Director/Board Member | 57 | 13-12-31 | |
Director/Board Member | 65 | 14-12-31 | |
Emil Hjalmarsson
BRD | Director/Board Member | 35 | 21-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,833,104 | 23,948,273 ( 61.67 %) | 0 | 61.67 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.98% | 36.84M | |
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.05% | 65.01B | |
+15.38% | 53.02B | |
+3.96% | 50.45B | |
+8.37% | 44.15B | |
+3.27% | 36.45B |
- Stock Market
- Equities
- BOUL Stock
- Company Boule Diagnostics AB